Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 17;3(1):126.
doi: 10.4102/jcmsa.v3i1.126. eCollection 2025.

Minor salivary gland tumours: Malignant or benign? A 10-year local retrospective review

Johan Grobbelaar  1 , Kathryne E Wright  2 , Ann Thomas  1 , Shaun E Adam  1
Affiliations

Minor salivary gland tumours: Malignant or benign? A 10-year local retrospective review

Johan Grobbelaar et al. J Coll Med S Afr. .

Abstract

Background: This study reports on our local incidence of minor salivary gland tumours (MSGT).

Methods: This was a retrospective descriptive study including all patients with MSGT treated at Tygerberg Hospital from 2015 to 2024.

Results: Benign and malignant tumours' incidence was almost equal at 46.46% and 53.54%, respectively (N = 99). Pleomorphic adenomas were the most common tumour overall (38.38%) and the most common benign tumour. Polymorphous low-grade adenocarcinoma (PLGA) was the most common malignant tumour (15.15%). The palate was the most common site. Primary sites other than lips and palate had a 93.23% malignant incidence. Benign tumours occurred statistically significantly in younger patients than malignant tumours (p < 0.001) (42.74 years versus 56.02 years).

Conclusion: We did not see the high malignant incidence that is frequently reported in otorhinolaryngology textbooks. Pleomorphic adenomas remain the most common and occur most commonly in the palate. We did show an unusually high incidence of PLGA. Primary sites other than palate and lips should raise the suspicion of malignant MSGT.

Contribution: The study highlights the importance of reporting on local data because disease patterns may vary greatly based on genetic and geographical differences. Further investigation is needed to explain possible local factors contributing to the high incidence of PLGA.

Keywords: benign; malignant; minor salivary gland tumours; pleomorphic adenoma; polymorphous adenocarcinoma; salivary gland tumours.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no financial or personal relationships that may have inappropriately influenced them in writing this article.

References

    1. Sunwoo J, Lewis J, Chafeej T. Cummings otolaryngology: Head and neck surgery. 6th ed. Philadelphia: Elsevier Mosby Publisher, 2015; p. 1258–1280.
    1. Jones AV, Craig GT, Speight PM, Franklin CD. The range and demographics of salivary gland tumours diagnosed in a UK population. Oral Oncol. 2008;44(4):407–417. 10.1016/j.oraloncology.2007.05.010 - DOI - PubMed
    1. Eveson JW, Cawson RA. Salivary gland tumours. A review of 2410 cases with particular reference to histological types, site, age and sex distribution. J Pathol. 1985;146(1):51–58. 10.1002/path.1711460106 - DOI - PubMed
    1. Hormer J, Robson A. Scott-Brown’s otorhinolaryngology and head and neck surgery. 8th ed. Vol. 3. Boca Raton: CRC press, 2018; p. 115–130.
    1. Beckhardt RN, Weber RS, Zane R, et al. Minor salivary gland tumors of the palate: Clinical and pathologic correlates of outcome. Laryngoscope. 1995;105(11):1155–1160. 10.1288/00005537-199511000-00003 - DOI - PubMed

LinkOut - more resources